Cygnus Capital Advisors’s Zymeworks ZYME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$205 Buy
8,197
+2,200
+37% +$52.1K 0.14% 52
2025
Q4
$158 Buy
+5,997
New +$131K 0.12% 53

Other funds holding ZYME

Cygnus Capital Advisors's ZYME Position: Q1 2026 in Review

Cygnus Capital Advisors increased its Zymeworks (ZYME) stake by 37% in Q1 2026, buying an estimated $52.1K and bringing the position to 8,197 shares worth $205. The position accounts for 0.14% of the portfolio, ranked #52.

Cygnus Capital Advisors first reported a position in ZYME in Q4 2025 and has held it in 2 quarters since. 211 funds tracked by Wall St. Rank hold ZYME as of Q1 2026.

  • Cygnus Capital Advisors held 8,197 shares of Zymeworks worth $205 as of Q1 2026.
  • Cygnus Capital Advisors bought 2,200 Zymeworks shares in Q1 2026, an estimated $52.1K.
  • Zymeworks made up 0.14% of Cygnus Capital Advisors's portfolio in Q1 2026, its #52 holding.
  • Cygnus Capital Advisors first reported a position in Zymeworks in Q4 2025 and has held it in 2 quarters since.
  • 211 funds tracked by Wall St. Rank held Zymeworks as of Q1 2026.

Based on Cygnus Capital Advisors's 13F filing for Q1 2026, filed 13 May 2026.